APA način citiranja

Landovitz, R. J., Li, S., Grinsztejn, B., Dawood, H., Liu, A. Y., Magnus, M., . . . Eron, J. J. (2018). Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med.

Čikaški stil citiranja

Landovitz, Raphael J., et al. "Safety, Tolerability, and Pharmacokinetics of Long-acting Injectable Cabotegravir in Low-risk HIV-uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled Trial." PLoS Med 2018.

MLA način citiranja

Landovitz, Raphael J., et al. "Safety, Tolerability, and Pharmacokinetics of Long-acting Injectable Cabotegravir in Low-risk HIV-uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled Trial." PLoS Med 2018.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.